Drug repurposing with network reinforcement
Abstract Background Drug repurposing has been motivated to ameliorate low probability of success in drug discovery. For the recent decade, many in silico attempts have received primary attention as a first step to alleviate the high cost and longevity. Such study has taken benefits of abundance, var...
Main Authors: | Yonghyun Nam, Myungjun Kim, Hang-Seok Chang, Hyunjung Shin |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-07-01
|
Series: | BMC Bioinformatics |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12859-019-2858-6 |
Similar Items
-
Indicator Regularized Non-Negative Matrix Factorization Method-Based Drug Repurposing for COVID-19
by: Xianfang Tang, et al.
Published: (2021-01-01) -
Drug Repurposing Using Biological Networks
by: Francisco Javier Somolinos, et al.
Published: (2021-06-01) -
SAveRUNNER: an R-based tool for drug repurposing
by: Giulia Fiscon, et al.
Published: (2021-03-01) -
An inference method from multi-layered structure of biomedical data
by: Myungjun Kim, et al.
Published: (2017-05-01) -
Systematic integration of biomedical knowledge prioritizes drugs for repurposing
by: Daniel Scott Himmelstein, et al.
Published: (2017-09-01)